Search research articles
Contact Us
Filters
Showing results (141-150 of 148) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 148 results.
Pediatric Blood & Cancer
|
April 4, 2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood
Juliane Schmäh, Birthe Fedders, Renate Panzer-Grümayer, et al.
Reviews in Cardiovascular Medicine
|
January 29, 2022
Evaluation of systemic inflammation in response to remote ischemic preconditioning in patients undergoing transcatheter aortic valve replacement (TAVR)
Kun Zhang, Willi Troeger, Matthias Kuhn, et al.
International Journal of Pharmaceutics
|
January 2, 2025
An updated overview on long-acting therapeutics for the prevention and treatment of human immunodeficiency virus (HIV) from a perspective of pharmaceutics
Linh Dinh, Jason T Blackard, Jaime Robertson, et al.
Blood
|
March 21, 2022
High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes
Lidia M Fernández-Sevilla, Jaris Valencia, Paula Ortiz-Sánchez, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group
Stefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
Human Vaccines & Immunotherapeutics
|
August 1, 2013
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
Cindy Tamminga, Martha Sedegah, Santina Maiolatesi, et al.
Academic Radiology
|
July 10, 2025
Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell Disorders
Markus Wennmann, Jessica Kächele, Arvin von Salomon, et al.
Plos One
|
October 18, 2011
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component
Cindy Tamminga, Martha Sedegah, David Regis, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 148) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 148 results.
Pediatric Blood & Cancer
|
April 4, 2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood
Juliane Schmäh, Birthe Fedders, Renate Panzer-Grümayer, et al.
Reviews in Cardiovascular Medicine
|
January 29, 2022
Evaluation of systemic inflammation in response to remote ischemic preconditioning in patients undergoing transcatheter aortic valve replacement (TAVR)
Kun Zhang, Willi Troeger, Matthias Kuhn, et al.
International Journal of Pharmaceutics
|
January 2, 2025
An updated overview on long-acting therapeutics for the prevention and treatment of human immunodeficiency virus (HIV) from a perspective of pharmaceutics
Linh Dinh, Jason T Blackard, Jaime Robertson, et al.
Blood
|
March 21, 2022
High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes
Lidia M Fernández-Sevilla, Jaris Valencia, Paula Ortiz-Sánchez, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group
Stefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
Human Vaccines & Immunotherapeutics
|
August 1, 2013
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
Cindy Tamminga, Martha Sedegah, Santina Maiolatesi, et al.
Academic Radiology
|
July 10, 2025
Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell Disorders
Markus Wennmann, Jessica Kächele, Arvin von Salomon, et al.
Plos One
|
October 18, 2011
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component
Cindy Tamminga, Martha Sedegah, David Regis, et al.
Page
of 15